secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0000950103-24-015811
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb borrows $400M in new term loans maturing May 2027
---------------------------------------------------------------

- Bausch + Lomb added $400M term loans under its credit agreement; proceeds used to repay revolver and for corporate purposes.
- Loans mature May 10, 2027, with quarterly amortization: 0.625% of principal for first 8 installments, then 1.875%.
- Interest at base rate or term SOFR plus margin: 2.25% (base) or 3.25% (SOFR); other terms unchanged.
- Bausch Health (BHC) filed the 8-K; the borrowing is at subsidiary Bausch + Lomb (BLCO).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000095010324015811/0000950103-24-015811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000095010324015811/dp220184_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-015811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer